After Micron provided weaker than expected Q2 guidance, Sterne Agee CRT says that the worst should be behind the company after next quarter. The firm thinks the company has a number of positive catalysts next quarter, including a new 3D NAND product and consolidation of Inotera capacity. It keeps a $19 price target and Buy rating on the shares.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here